Skip to content
DataLookout
Menu

Pfizer clinical trial pipeline

Get alerts when Pfizer's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19

What changed in the last 30 days

76 trials changed in the last 30 days: 2 stopped, 17 with notable changes, 57 with minor changes only.

  1. Notable: Symbiotic-Lung · 04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy and With Tarlatamab, Alone or With Chemotherapy, · Extensive-Stage Small Cell Lung Cancer Primary endpoint(s) modified PfizerPhase 2/3 NCT07226999
  2. Notable: Continuation Study of Tilrekimig · Moderate-to-Severe Long-Term Breathing Difficulty, Known by the Medical Term of Chronic Obstructive Pulmonary Disease (COPD) to Learn About This Medicine When Used for a Long Period of Time Recruitment opened PfizerPhase 3 NCT07839884
  3. Minor: Real-world Study to Learn About of the Characteristics and Outcomes of Advanced or Metastatic Bladder Cancer · Different Histologies Trial status changed: Not Yet Recruiting → Active, Not Recruiting PfizerNot specified NCT07897669
  4. Minor: How a New Pneumococcal Vaccine Works in Infants Trial sites expanded: 130 → 134 locations PfizerPhase 3 NCT07629440
  5. Minor: PF-08165784 · PIK3CA-Mutated Advanced or Metastatic Solid Tumors Trial sites expanded: 0 → 5 locations PfizerPhase 1 NCT07897721
  6. Notable: (Called Marstacimab) · Hemophilia A or B Recruitment opened PfizerNot specified NCT07859527
  7. Minor: XRPMS · Korean Post-marketing Surveillance for Xeljanz XR Trial completed PfizerNot specified NCT04876781
  8. Minor: ENDEAVOUR-UC · Etrasimod · Moderate to Severe Ulcerative Colitis Enrollment closed, study ongoing PfizerNot specified NCT06398626
  9. Minor: Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec · Hemophilia A or B Respectively Trial sites expanded: 39 → 44 locations PfizerPhase 3 NCT05568719
  10. Minor: MOUNTAINEER-03 · Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer Enrollment closed, study ongoing Seagen, a wholly owned subsidiary of PfizerPhase 3 NCT05253651
  11. Minor: PF-08098488 · Advanced Solid Tumors Start date changed from estimate of Oct 29, 2026 to Nov 5, 2026 PfizerPhase 1 NCT07903415
  12. Notable: Somatrogon · Pediatric Growth Hormone Deficiency (p GHD) in India Primary completion pushed from Sep 21, 2026 to Sep 5, 2028 PfizerNot specified NCT06587035
  13. Minor: Lots of a Multivalent Pneumococcal Conjugate Vaccine Administered to Adults Enrollment closed, study ongoing PfizerPhase 3 NCT07794748
  14. Minor: Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema Enrollment closed, study ongoing PfizerPhase 3 NCT06807268
  15. Minor: ATGAM General Investigation Primary and study completion pushed from Jan 22, 2027 to Mar 26, 2027 PfizerNot specified NCT06039020
  16. Minor: This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works · Non-small Cell Lung Cancer With High Levels of PD-L1 Trial sites expanded: 389 → 392 locations PfizerPhase 3 NCT06758401
  17. Notable: Atirmociclib in Combination With Giredestrant · ER-positive, HER2-negative Early-stage Breast Cancer Primary endpoint(s) modified PfizerPhase 3 NCT07890597
  18. Notable: CDK4i · PF-07220060 · Advance Solid Tumors Phase changed: Phase 1/2 → Phase 2 PfizerPhase 2 NCT04557449
  19. Minor: 16-Week Study to Learn About the Study Medicine Called Ritlecitinib · Long Lasting Painful Red Skin Lumps, Known by the Medical Term, Hidradenitis Suppurativa, or HS Trial sites reduced: 60 → 57 locations PfizerPhase 2 NCT07228390
  20. Minor: Vepdegestrant (ARV-471, PF-07850327) · ER+/HER2- Locally Advanced or Metastatic Breast Cancer (BC) Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Active, Not Recruiting PfizerPhase 1 NCT05463952
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-11-12 NCT07932925 The Purpose of This Study is to Learn About the Safety and Effectiveness of Berobenatide… Phase 3 Not Yet Recruiting
2026-11-12 NCT07933835 A Study to Learn How Different Amounts of the Study Medicine Called PF-08166744 Are… Phase 1 Not Yet Recruiting
2026-11-12 NCT07933848 A Study to Learn About the Study Medicine Called Prifetrastat in People With Renal… Phase 1 Not Yet Recruiting
2026-11-09 NCT07923981 A Study to Assess the Safety of Marstacimab and How Well it Works in People With Mild to… Phase 3 Recruiting
2026-11-09 NCT07927023 A Study to Learn About a Medicine (Called Elranatamab) in People With Relapsed Refractory… Not Yet Recruiting
2026-11-05 NCT07919678 A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and… Phase 3 Recruiting
2026-11-04 NCT07915609 A Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis… Phase 3 Recruiting
2026-11-02 NCT07909122 Real-World Treatment Patterns and Effectiveness of Anti-EGFR- and Anti-VEGF-based… Not Yet Recruiting
2026-10-30 NCT07906262 Efficacy of Rimegepant 75 mg for the Acute Treatment of Migraine: a Bayesian Individual… Active, Not Recruiting
2026-10-29 NCT07903415 A Study to Learn About the Study Medicine Called PF-08098488 in People With Advanced… Phase 1 Recruiting

Active trials by phase

Phase 1
46
Phase 1/2
10
Phase 2
29
Phase 2/3
5
Phase 3
94
Phase 4
10
Not charted: 67 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials, top 10 of 54

Get alerts when Pfizer's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free